Arkolith/Insider Trading/CLVS/Form 4

Harding Thomas C.

See RemarksClovis Oncology, Inc. (CLVS) · full profile →Form 4 · filed Aug 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2022Sell(S)802$1.46$1K15K
Aug 2, 2022Sell(S)77$1.46$1123K
Aug 2, 2022Sell(S)930$1.46$1K16K
Aug 1, 2022Option exercise(M)2K——16K
Aug 1, 2022Option exercise(M)2K——17K
Aug 1, 2022Option exercise(M)181——3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2022Option exercise(M)2K—$011K
Aug 1, 2022Option exercise(M)2K—$03K
Aug 1, 2022Option exercise(M)181—$01K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-027574) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML